The global antiretroviral drug market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Antiretroviral is the category of drugs that are used, act, or are effective against retroviruses particularly to treat HIV. The major driving factors contributing to the market growth include the rising prevalence and burden of HIV, growing investment in R&D related to these drugs coupled with the rise in the availability of novel drugs that pose better efficacy than ever before. These drugs are available in several categories that majorly include Integrase Inhibitors, Protease Inhibitors, Multi-class Combination Products, Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) and others.

According to the US Department of Health & Human Services, in the year 2018, there were nearly 37.9 million people globally living with HIV/AIDS. An estimated 1.7 million individuals globally became newly infected with HIV in 2018. Currently, antiretrovirals are considered to be the basis of HIV/AIDS treatment, since there is no solid cure or a preventive vaccine available for HIV. In the case of a non-resistant strain of HIV, antiretroviral treatment can restrain the replication of HIV in the majority of cases. Thus, the presence of a huge patient pool demands anti-retroviral drugs for the treatment which is projected to drive the growth of the market during the forecast period. 

Some key players operating in the market include AbbVie Inc., Boehringer Ingelheim, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd, Gilead Sciences, among others. These players are aiming to strengthen their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launches and development in the existing product portfolio, and so on.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape:  AbbVie Inc., Boehringer Ingelheim, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd, Gilead Sciences, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Antiretroviral Drug Market by Segments

By Drug Class 

• Integrase Inhibitors

• Protease Inhibitors

• Multi-class Combination Products

• Nucleoside Reverse Transcriptase Inhibitors

• Non-Nucleoside Reverse Transcriptase Inhibitors

• Others 

Global Antiretroviral Drug Market by Region